MEDTRONIC INC 4
4 · MEDTRONIC INC · Filed Jan 29, 2015
Insider Transaction Report
Form 4
Lerman Bradley E
SVP General Counsel & Corp Sec
Transactions
- Disposition to Issuer
Employee Stock Option (right to buy)
2015-01-26−39,835→ 0 totalExercise: $62.76Exp: 2024-07-28→ Common stock (39,835 underlying) - Disposition to Issuer
Common stock
2015-01-26−42,458.855→ 0 total - Disposition to Issuer
Employee Stock Option (right to buy)
2015-01-26−1,594→ 0 totalExercise: $62.76Exp: 2024-07-28→ Common stock (1,594 underlying)
Footnotes (3)
- [F1]Represents shares of Medtronic, Inc. ("Medtronic"), including a balance increase of 631.855 shares since the officer's last Form 4 filing due to exempt transactions such as dividend reinvestment, disposed of pursuant to the merger (the "Merger") of a wholly-owned subsidiary of Medtronic plc ("New Medtronic") with and into Medtronic, with Medtronic surviving as a wholly-owned subsidiary of New Medtronic, in exchange for ordinary shares of New Medtronic, which was consummated after and conditioned on New Medtronic's acquisition of Covidien plc, by means of a "scheme of arrangement", an Irish statutory procedure under the Companies Act of 1963. At the effective time of the Merger, each Medtronic common share was cancelled and converted into the right to receive one New Medtronic ordinary share. Under the terms of the Merger, the officer received cash in lieu of fractional shares of New Medtronic and restricted stock units were rounded up to the nearest whole share.
- [F2]This option, which was unvested at the effective time of the Merger, was assumed by New Medtronic in the Merger and converted into an option to purchase 1,594 ordinary shares of New Medtronic for $62.76 per share with the same terms and conditions as the original Medtronic stock option.
- [F3]This option, which was unvested at the effective time of the Merger, was assumed by New Medtronic in the Merger and converted into an option to purchase 39,835 ordinary shares of New Medtronic for $62.76 per share with the same terms and conditions as the original Medtronic stock option.